Lung Cancer Prevention Trial Progress and PCI Pharma Services Manufacturing Agreement
Press Release, January 29, 2019
NewsResearch
Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells that have undergone Malignancy Associated Change
Press Release, April 16, 2018
Research
VisionGate Lung Cancer 3D Cellular Imaging Research to be Featured as a Late-Breaking Abstract at the AACR Annual Meeting 2018
Press Release, April 12, 2018
NewsResearch
VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services
Press Release, April 5, 2018
NewsResearch
New Research Study Demonstrates Applicability of 3-D Cell-CT™ Imaging and Analysis Platform
Press Release, December 12, 2017
NewsPublicationsResearch
Advances in Lung Cancer Early Detection and Treatment at the World Conference on Lung Cancer
Press Release, October 19, 2017
NewsResearch
Blinded Trial Data Could Help Alleviate Worry Over Incidental Lung Nodule Findings
VisionGate Presents Blinded Trial Data at WCLC 2016
NewsResearch
LuCED Test and New Drug Therapy to Prevent Lung Cancer
Demonstrate Promise in National Surveys of Pulmonologists
NewsResearch
Lung Cancer Pioneers Create Lung Cancer Eradication Pact
Partnership Would Combine Company’s Patented Technology that Detects Pre-cancer of the Lungs with Drug Treatment that Prevents Cancer
Research
VisionGate’s LuCED Shows Promise for Lung Cancer Screening
Blinded Trial Results Released at WCLC2015
NewsResearch
New Data Demonstrates VisionGate’s LuCED® Test Able to Detect Early Cancer
Early Cancer Detection Even From Small Nodules
NewsResearch
New Study Shows High Sensitivity and Specificity for LuCED® Test to Help Detect Lung Cancer Earlier
Data to be Presented at ASCO 2014 Demonstrates that Non-Invasive LuCED Test Detects Stage I and II Lung Cancer [...]
Research
VisionGate Presents Clinical Data at IASLC Meeting
VisionGate Presents Clinical Data at IASLC Meeting Showing its Cell-CT 3D Imaging Platorm detects Lung Cancer with High Sensitivity and Specificity
Research
Adjunctive use of its 3D cell imaging platform can increase utility of CT screening for Lung Cancer
IASLC_Press_Release_063011_FINAL_FOR WEBSITE POSTING
NewsPublicationsResearch
Game Changer for Lung Cancer Announced
NATIONAL EXPERT PANEL RECOMMENDS ANNUAL CT SCANS FOR THOSE AT HIGH RISK FOR LUNG CANCER; PUBLIC AND PRIVATE REIMBURSEMENTS EXPECTED TO FOLLOW [...]
Research
VisionGate reports advances in it’s Cell-CT 3D cell analysis platform
VisionGate reports advances in it's Cell-CT automated 3D cell analysis platform at ASC 2012 Scientific Meeting
NewsResearch
Columnar Cell
The cell is shown in maximum intensity projection. In the center and right panels, color and opacity have been adjusted to render [...]
Research
Adenocarcinoma
The cell is shown in maximum intensity projection. In the center and right panels, color and opacity have been adjusted to render [...]
Research
Cell-CT
The Cell-CT™ uses a technique called Optical Projection Tomography to render cells in 3D. This process is illustrated in the video where [...]
Research
Patients FAQ’s
Learn more about our LuCED® lung test, VisionGate’s non-invasive diagnostic test to aid physicians in the early detection of lung cancer.
Diagnostic TestsResearch
Physicians FAQ’s
The LuCED® lung test is a non-invasive, cost-effective test to precede, supplement or follow low-dose CT scans.
Diagnostic TestsResearch
Researchers FAQ’s
VisionGate has ongoing research opportunities and continues to grow its team of collaborative partners from around the world.
Diagnostic TestsResearch
Diagnostics Pipeline
VisionGate is developing the sputum-based LuCED test to aid in early detection of lung cancer.
Diagnostic TestsResearch
LuCED test development at the 24th International Conference for Lung cancer screening
Getting a Better Look at Lung Nodules: Cell Scan Delivers Images Without X-rays An Interview With Thomas Neumann, MD Author: Anita Shaffer [...]
Research
The city of Phoenix is opening the world’s first biomedical 3D cellular imaging lab
The Cell-CT™ research lab, located on the Phoenix Biomedical Campus in downtown Phoenix, is seeking proposals from researchers in universities and nonprofit organizations to utilize the Cell-CT™ imaging device.
Research
VisionGate, Inc. announced five abstracts describing its Cell-CT™ system for 3D cellular imaging
VisionGate, Inc. presented abstracts describing its Cell-CT system and the Lung Cell Evaluation Device test (LuCED), for early detection of lung cancer, at [...]
NewsResearch
Peer-reviewed publication in Pattern Recognition demonstrates superiority of Cell-CT™
Seattle, WA, September 29, 2008 – VisionGate, a privately held biomed/biotech company, today announced the publisher’s notification of acceptance of a study [...]
NewsPublicationsResearch
